Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 22 resultados

SYNTHIA: Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applica... SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in he...
2024-08-09 - 2029-08-31 | Financiado

EDiHTA: The first European Digital Health Technology Assessment framework co-created by all stakeholders alo... NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 Digital health technologies (DHTs) are expected to improve both the quality and delivery of healthcare services for European societies while...
2023-11-28 - 2027-12-31 | Financiado

PREDICTOM: PREDICTION OF ALZHEIMER S DISEASE USING AN AI DRIVEN SCREENING PLATFORM NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Alzheimer’s disease (AD) and related disorders leading to dementia are associated with staggering costs and suffering. Recently, there has b...
2023-10-30 - 2027-10-31 | Financiado

IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-05-10 - 2028-03-31 | Financiado

HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY PLUS NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2019-19-single-stage Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be e...
2020-05-26 - 2024-03-31 | Financiado

CoroPrevention: Personalized Prevention for Coronary Heart Disease NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-SC1-BHC-2018-2020 European Coronary Heart Disease (CHD) burden is unsustainable. Better risk stratification tools and personalized care of patients are needed...
2019-12-13 - 2026-12-31 | Financiado

ERA4TB: EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms...
2019-12-12 - 2025-12-31 | Financiado

VALUE-Dx: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use Antimicrobial resistance (AMR) is of great public health concern, causing numerous losses of lives worldwide and threatening to reverse many...
2019-03-25 - 2024-09-30 | Financiado

NEURONET: Efficiently Networking European Neurodegeneration Research NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage The main aim of NEURONET is to set up an efficient platform to boost synergy and collaboration across the IMI projects of the Neurodegenerat...
2019-02-28 - 2022-08-31 | Financiado

HTx: Next Generation Health Technology Assessment to support patient centred societally oriented real t... NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-SC1-BHC-2018-2020 HTx will create a framework for next generation Health Technology Assessment (HTA) that supports patient-centred, societally oriented, and r...
2018-12-03 - 2024-06-30 | Financiado

EHDEN: European Health Data and Evidence Network NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage Europe is generating huge amounts of patient-level information contained in Electronic Health Record (EHR) systems and other types of health...
2018-11-22 - 2024-10-31 | Financiado

GetReal Initiative: The GetReal Initiative NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2017-11-single-stage The GetReal Initiative brings together partners from the IMI GetReal project to drive the adoption of tools, methodologies and best practice...
2018-06-26 - 2021-04-30 | Financiado

IMPACT HTA: Improved Methods and Actionable Tools for Enhancing Health Technology Assessment NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-SC1-2016-2017 IMPACT HTA proposes new and improved methods, tools and guidance for decision-makers across ten research areas in the context of HTA and hea...
2017-11-21 - 2021-06-30 | Financiado

DO-IT: Big Data for Better Outcomes Policy Innovation and Healthcare System Transformation Sofia ref. 1... NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage The overall goal of the Big Data for Better Outcomes (BD4BO) programme is to facilitate the use of ‘big data’ to promote the development of...
2017-01-30 - 2019-01-31 | Financiado

HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY Sofia ref.... NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in qual...
2016-12-22 - 2023-06-30 | Financiado

ROADMAP: Real world Outcomes across the AD spectrum for better care Multimodal data Access Platform Sofia... NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage The aim of ROADMAP is to provide the foundation for a Europe-wide real world evidence (RWE) platform in AD by piloting multi-modal data inte...
2016-12-21 - 2018-10-31 | Financiado

ADAPT-SMART: Accelerated Development of Appropriate Patient Therapies a Sustainable Multi stakeholder Approach... NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un H2020: H2020-JTI-IMI2-2015-04-two-stage-Master Progress in the life sciences and related technologies offer great potential for therapeutic benefits to patients in need. However, major ad...
2015-09-02 - 2018-04-30 | Financiado

GETREAL: Incorporating real-life clinical data into drug development NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un FP6: When a new medicine reaches the market, it is accompanied by an extensive data package that provides information about the safety and effica...
2013-10-01 - 2017-03-31 | Financiado

EQUIPT: European study on Quantifying Utility of Investment in Protection from Tobacco NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un FP7: Tobacco smoking costs the EU an estimated 98 to 130 billion Euros each year – just above 1% of the EU Gross Domestic Product in 2000. A larg...
Financiado

GETREAL: Incorporating real life clinical data into drug development NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE participó en un FP7: When a new medicine reaches the market, it is accompanied by an extensive data package that provides information about the safety and effica...
Financiado

NICE